%0 Journal Article
%T Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
%A Changping Wu
%A Haiyan Wu
%A Jianming Xu
%A Jin Li
%A Lin Shen
%A Ruihua Xu
%A Shujun Yang
%A Shukui Qin
%A Tianshu Liu
%A Yanru Qin
%A Yilin Ge
%A Yixiang Mao
%A Yuxian Bai
%J Archive of "Cancer Communications".
%D 2019
%R 10.1186/s40880-019-0384-6
%X The online version of this article (10.1186/s40880-019-0384-6) contains supplementary material, which is available to authorized users
%K Gastric cancer
%K Gastroesophageal junction cancer
%K HER2
%K Pertuzumab
%K Trastuzumab
%K Chemotherapy
%K Overall survival
%K Progression-free survival
%K Safety
%K China
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591878/